Log in

Relevant bibliographies by topics / Kaposi's sarcoma

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers

Academic literature on the topic 'Kaposi's sarcoma'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 August 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Kaposi's sarcoma.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Kaposi's sarcoma"

1

Santos, Mônica, Virginia Vilasboas, Luciana Mendes, Carolina Talhari, and Sinésio Talhari. "Lymphangiectatic Kaposi's sarcoma in a patient with AIDS." Anais Brasileiros de Dermatologia 88, no. 2 (April 2013): 276–78. http://dx.doi.org/10.1590/s0365-05962013000200019.

Full text

Abstract:

Kaposi's sarcoma is a malignant disease that originates in the lymphatic endothelium. It has a broad spectrum of clinical manifestations. Its four distinct clinical forms are: classic, endemic, iatrogenic and epidemic Kaposi's sarcoma. In non-HIV-associated Kaposi's sarcoma, the disease is typically limited to the lower extremities, but in immunodeficient patients, it is a multifocal systemic disease. The clinical course of the disease differs among patients, ranging from a single or a few indolent lesions to an aggressive diffuse disease. Advanced Kaposi's sarcoma lesions, typically those on the lower extremities, are often associated with lymphedema. In this paper, we report a case of a patient with a rare form of AIDS-associated Kaposi sarcoma called lymphangiectatic Kaposis's sarcoma.

APA, Harvard, Vancouver, ISO, and other styles

2

Bushati, Teona, Leart Berdica, Albina Ndoja, Erion Sukaj, Ilirian Ibrushi, and Leon Kaza. "Scrotal Kaposi's Sarcoma in HIV-negative Patient: A Case Report and Review of the Literature." Albanian Journal of Trauma and Emergency Surgery 7, no. 2 (July 20, 2023): 1304–7. http://dx.doi.org/10.32391/ajtes.v7i2.260.

Full text

Abstract:

Background: Kaposi's sarcoma (KS) is an indolent angio-proliferative tumor proliferation with spindle cells originating from endothelial and immune cells infected with human herpes virus type 8. (HHV-8: also known as Kaposi sarcoma herpes virus [KSHV]). HHV-8 was identified as the causative agent of KS. This virus is present in 95-98% of cases with KS. Kaposi's sarcoma was first described by a Hungarian dermatologist 1872 named Moritz Kaposi.[1] The lesions are characterized by the proliferation of spindle cells of endothelial origin, which present different degrees of abnormal vascularization, inflammatory infiltrates, and fibrosis. Kaposi's Sarcoma (KS) is a malignancy that generally affects the skin, and can be systemic with internal organ involvement. It originates from the vascular endothelium. KS's relationship with human immunodeficiency virus (HIV) infection is well known. In this article, we will present a 73-year-old male patient with 3 purple scrotal lesions up to 0.5 cm in size. Conclusion; Kaposi's sarcoma of the scrotum in a negative patient is a rare pathology. However, in cases of scrotal lesions that last over time, a differential diagnosis should be made and Kaposi's sarcoma should be taken into consideration. Also, a screening for other accompanying lesions, especially a detailed examination of the gastrointestinal tract is important in cases of Kaposi’s sarcoma of the scrotum.

APA, Harvard, Vancouver, ISO, and other styles

3

Dertlioğlu, Selma Bakar. "Kaposi Sarcoma of the Lower Extremity with HIV and Kaposi's Sarcoma." Journal of Clinical Case Reports and Studies 2, no. 1 (July 1, 2021): 01–03. http://dx.doi.org/10.31579/2690-8808/059.

Full text

Abstract:

Kaposi's sarcoma is the most common malignancy seen with HIV infection. It is a lymphoangioproliferous tumor first described by Moritz Kaposi in 1872. It is characterized by bluish red or dark brown plaques and nodules, especially in the distal of the lower extremities, often the heels and feet. Organ involvement without skin findings is observed in approximately 15% of the cases. There are four clinical variants, the classical, endemic, iatrogenic and the epidemic associated with AIDS. Kaposi's sarcoma in AIDS cases apart from the skin, it can also be seen in the oral cavity, gastro-intestinal system and respiratory system. Antiretroviral therapy (ART) should be started immediately in newly diagnosed HIV infected patients. In this research, a 65 year old male patient, who was diagnosed AIDS and Kaposi's sarcoma at the same time, is described.

APA, Harvard, Vancouver, ISO, and other styles

4

Merimsky, Ofer, and Samario Chaitchik. "Kaposi's Sarcoma on a Lymphedematous Arm following Radical Mastectomy." Tumori Journal 78, no. 6 (December 1992): 407–8. http://dx.doi.org/10.1177/030089169207800614.

Full text

Abstract:

Chronic lymphedema predisposes for local Immune incompetence, manifested by development of Stuart-Treves syndrome, Kaposi's sarcoma and fibroma-like lesions. A 91-year-old female with multiple cancers developed classic Kaposi's sarcoma on a chronically lymphedematous arm 26 years after radical mastectomy and irradiation of the involved axilla. The Kaposi lesion partially responded to electron beam irradiation.

APA, Harvard, Vancouver, ISO, and other styles

5

Ellis, Harold. "Moritz (Maurice) Kaposi: Kaposi's Sarcoma." Journal of Perioperative Practice 23, no. 9 (September 2013): 208. http://dx.doi.org/10.1177/175045891302300906.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Gruffat, Henri, Alain Sergeant, and Evelyne Manet. "Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma." Microbes and Infection 2, no. 6 (May 2000): 671–80. http://dx.doi.org/10.1016/s1286-4579(00)00358-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

DiAlberti, L., G. G. Teo, S. Porter, J. Zakrzewska, and C. Scully. "Kaposi's sarcoma herpesvirus in oral kaposi's sarcoma." European Journal of Cancer Part B: Oral Oncology 32, no. 1 (January 1996): 68–69. http://dx.doi.org/10.1016/0964-1955(96)00003-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Ognibene, Frederick P., and James H. Shelhamer. "Kaposi's Sarcoma." Clinics in Chest Medicine 9, no. 3 (September 1988): 459–65. http://dx.doi.org/10.1016/s0272-5231(21)00523-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

James, D. Geraint. "Kaposi's sarcoma." Journal of Medical Biography 19, no. 1 (February 2011): 14. http://dx.doi.org/10.1258/jmb.2009.009084.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Antman, Karen, and Yuan Chang. "Kaposi's Sarcoma." New England Journal of Medicine 342, no. 14 (April 6, 2000): 1027–38. http://dx.doi.org/10.1056/nejm200004063421407.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Kaposi's sarcoma"

1

Kimball, Louise Elizabeth. "Humoral immune response to Kaposi's sarcoma-associated herpesvirus in persons with and without Kaposi's sarcoma /." Thesis, Connect to this title online; UW restricted, 2003. http://hdl.handle.net/1773/9284.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Wiggins, Charles Lamar. "Kaposi's sarcoma and sexually transmitted disease /." Thesis, Connect to this title online; UW restricted, 1999. http://hdl.handle.net/1773/10933.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Whitby, Denise. "Human herpesvirus 8 (HHV-8) and Kaposi's sarcoma." Thesis, Institute of Cancer Research (University Of London), 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.368195.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Kubo, Toru. "Human immune responses against Kaposi's Sarcoma-associated Herpesvirus (KSHV)." Thesis, Imperial College London, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.429041.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Malik, Poonam. "The multifunctional ORF57 protein of Kaposi's sarcoma-associated herpesvirus." Thesis, University of Glasgow, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.400755.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Mayama, Satoshi. "Seroprevalence and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus." Thesis, University of Liverpool, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.405058.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Pozniak, Anton Louis. "HIV-related tuberculosis and pulmonary Kaposi's Sarcoma in Zimbabwe." Thesis, University of Bristol, 1993. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.241119.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Durrington, Hannah Jane. "Kaposi's sarcoma-associated herpesvirus and bone morphogenetic protein signalling." Thesis, University of Cambridge, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.608400.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Wakeham, Katie. "The epidemiology of Kaposi's sarcoma associated-herpesvirus in Uganda." Thesis, University of York, 2013. http://etheses.whiterose.ac.uk/4518/.

Full text

Abstract:

Over the past two decades there has been an explosion in the number of cases of Kaposi’s sarcoma (KS) in parts of sub-Saharan Africa, where Kaposi’s sarcoma associated-herpesvirus (KSHV) and HIV are relatively prevalent. Currently KS is the most commonly reported cancer in Uganda causing significant morbidity and mortality. Limiting KSHV transmission or halting disease progression could prevent KS. Here, I describe an investigation of factors that might impact on transmission of KSHV and report the first prospective study of antibody titre to KSHV to determine risk of KS from Africa. Stored samples from Medical Research Council, Uganda cohorts were tested using an ELISA to KSHV antigens. Results from a birth cohort found that among both mothers and children malaria parasitaemia was identified as a novel association with KSHV seropositivity. Among children HIV exposure and HIV infection was associated with antibodies to KSHV. A random effects meta-analysis conducted to clarify wider evidence of an association between KSHV and HIV found that HIV was associated with an increased prevalence of antibodies to KSHV in mothers and children. A case-control study nested within a longitudinal HIV cohort found among individuals who develop KS, antibody titres to KSHV are higher and increased over time compared to adults who did not. It is plausible that control of malaria may also reduce the spread of KSHV. How malaria may interact with KSHV and if malaria control will reduce transmission are key future questions. Prevention and treatment of HIV with anti-retroviral therapy may lower KSHV transmission between mothers and children. For individuals with HIV-KSHV co-infection, increasing antibody titre to KSHV precedes development of KS. Research is required to elucidate co-factors driving progression to cancer. A clinically valid tool to screen for risk of HIV-associated KS is urgently needed.

APA, Harvard, Vancouver, ISO, and other styles

10

Owen, Christopher Bradley. "Utilising omics approaches to understand Kaposi's sarcoma-associated herpesvirus." Thesis, University of Leeds, 2015. http://etheses.whiterose.ac.uk/11782/.

Full text

Abstract:

Kaposi’s sarcoma-associated herpesvirus (KSHV) is an oncogenic human virus associated with a number of malignancies, including Kaposi’s sarcoma. Similar to all herpesviruses, KSHV establishes either latent or lytic infections in host cells. The latent stage involves minimal viral gene expression, enabling the virus to remain dormant, maintaining genome integrity and enabling viral persistence. Conversely, lytic replication is characterised by the expression of a highly regulated and coordinated cascade of viral gene expression, ultimately resulting in the production of new mature, infectious virions. Importantly, lytic replication is necessary for the development and spread of Kaposi’s sarcoma. State of the art high throughput, high resolution “omics” approaches, such as mass spectrometry-based quantitative proteomics and next generation sequencing-based transcriptomics, are rapidly becoming the techniques of choice for discovering novel biological phenomena due, in part, to their sensitivity and the ability to repeatedly ask new questions of an existing dataset. Herein, three high throughput, high resolution approaches, namely SILAC-based quantitative proteomics, miRNA sequencing and mRNA sequencing are employed in an attempt to identify and characterise novel interactions between KSHV and the host cell. Utilising quantitative proteomics, the essential host cell splicing factor Prp19 is identified as a novel interacting partner of the lytic KSHV ORF57 protein in subnuclear bodies. This interaction, surprisingly, does not contribute to viral mRNA maturation, but instead has implications for the cellular DNA damage response, appearing to limit the effectiveness of this important pathway, possibly to reduce any negative effects on viral replication. Proteomic analyses also highlighted a link between KSHV lytic replication and host miRNA biogenesis pathways. Through the application of miRNA sequencing, two host miRNAs, namely miR-151a-5p and miR-365a-3p, were found to be dysregulated during KSHV infection. Importantly, neither of these miRNAs appear to represent a host antiviral response. Instead, cellular target mRNAs are identified for miR-365a-3p, through the use of mRNA sequencing. These targets, termed DOCK5 and PRUNE2 are rapidly degraded during KSHV lytic replication via the viral-mediated upregulation of miR-365a-3p expression. Subsequent analysis of DOCK5 function during lytic replication suggests this interaction may promote viral egress. The data presented herein sheds light on previously unidentified mechanisms employed by KSHV to hijack the host cell, and may aid in the development of novel therapeutics against this important pathogen.

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Kaposi's sarcoma"

1

Decio, Cerimele, ed. Kaposi's sarcoma. New York: Medical & Scientific Books, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

BACUP and Cancer Information Service, eds. Understanding Kaposi's sarcoma. London: BACUP, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Stella, Wood, and BACUP, eds. Understanding Kaposi's sarcoma. London: BACUP, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

J, Gottlieb Geoffrey, and Ackerman A. Bernard 1936-, eds. Kaposi's sarcoma: A text and atlas. Philadelphia: Lea & Febiger, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

1938-, Ziegler John L., and Dorfman Ronald F, eds. Kaposi's sarcoma: Pathophysiology and clinical management. New York: Dekker, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Penn, Israel. The etiology of Kaposi's sarcoma. Bethesda, MD (Bldg. 89, Rm. 103, Bethesda 20892): U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, International Cancer Research Data Bank, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Penn, Israel. The etiology of Kaposi's sarcoma. Bethesda, MD (Bldg. 89, Rm. 103, Bethesda 20892): U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, International Cancer Research Data Bank, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

G, Giraldo, ed. Recent advances in AIDS and Kaposi's sarcoma. Basel: Karger, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Kalamkari͡an, A. A. Sarkoma Kaposhi. Novosibirsk: Izd-vo "Nauka," Sibirskoe otd-nie, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

G, Giraldo, World Health Organization, and International Symposium on AIDS and Associated Cancers in Africa (2nd : 1987 : Naples, Italy), eds. AIDS and associated cancers in Africa: 2nd international symposium, Naples, October 7-9, 1987. Basel: Karger, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Kaposi's sarcoma"

1

Yaeger, Theodore E., Theodore E. Yaeger, Theodore E. Yaeger, Stephan Mose, Ramesh Rengan, and Charles R. Thomas. "Kaposi's Sarcoma." In Encyclopedia of Radiation Oncology, 405. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-540-85516-3_11002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Benati, Elisa. "Kaposi's sarcoma." In Diagnosing the Less Common Skin Tumors, 139–42. Boca Raton : CRC Press, [2019]: CRC Press, 2019. http://dx.doi.org/10.1201/9781315100555-35.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Fawaz, Bilal, and Debjani Sahni. "Kaposi's Sarcoma." In Advanced Skin Cancer, 115–30. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/9780429026683-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Schulman, Sarah. "Fame, shame, and kaposi's sarcoma." In My American History, 228–32. Second edition. | Abingdon, Oxon;: Routledge, 2018. http://dx.doi.org/10.4324/9781315121765-55.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Chang, Yuan, Shou-Jiang Gao, and Patrick S. Moore. "Kaposi's Sarcoma-Associated Herpesvirus (KSHV/HHV8)." In Clinical Virology, 549–74. Washington, DC, USA: ASM Press, 2016. http://dx.doi.org/10.1128/9781555819439.ch26.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Spira, Thomas J., and Harold W. Jaffe. "Human Herpesvirus 8 and Kaposi's Sarcoma." In Emerging Infections 2, 81–104. Washington, DC, USA: ASM Press, 2014. http://dx.doi.org/10.1128/9781555816957.ch4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Schulz, Thomas F., Yuan Chang, and Patrick S. Moore. "Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8)." In Human Tumor Viruses, 87–134. Washington, DC, USA: ASM Press, 2014. http://dx.doi.org/10.1128/9781555818289.ch3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Kalt, Inna, Shiri-Rivka Masa, and Ronit Sarid. "Linking the Kaposi's Sarcoma-Associated Herpesvirus (KSHV/HHV-8) to Human Malignancies." In Methods in Molecular Biology, 387–407. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-59745-416-2_19.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Zeitler, H. J., and B. Andondonskaja-Renz. "PTERIDINE LEVELS IN PATIENTS WITH AIDS (ACQUIRED IMMUNODEFICIENCY SYNDROME) AND WITH KAPOSI'S SARCOMA." In February 23–March 2, 1985, St. Christoph, Arlberg, Austria, edited by Helmut Wachter, H. Ch Curtius, and W. Pfleiderer, 593–606. Berlin, Boston: De Gruyter, 1985. http://dx.doi.org/10.1515/9783110860566-053.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Gloster, Hugh Morris, Lauren E. Gebauer, and Rachel L. Mistur. "Kaposi’s Sarcoma." In Absolute Dermatology Review, 379–80. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-03218-4_87.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Kaposi's sarcoma"

1

Haseena, S., and S. Renganayaki. "Automatic Kaposi's sarcoma detection using texture distinctiveness." In 2015 International Conference on Circuit, Power and Computing Technologies (ICCPCT). IEEE, 2015. http://dx.doi.org/10.1109/iccpct.2015.7159349.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

"Computer analysis of genes associated with Kaposi's sarcoma." In Bioinformatics of Genome Regulation and Structure/Systems Biology (BGRS/SB-2022) :. Institute of Cytology and Genetics, the Siberian Branch of the Russian Academy of Sciences, 2022. http://dx.doi.org/10.18699/sbb-2022-109.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Gandjbakhche, Amir H., Abby Vogel, Franck Amyot, Victor Chernomordik, Stavros Demos, Karen Aleman, Richard Little, Robert Yarchoan, and Moinuddin Hassan. "Noninvasive Multimodality Imaging Techniques to Assess Kaposi's Sarcoma." In 2005 27th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE, 2005. http://dx.doi.org/10.1109/iembs.2005.1616508.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Vogel, Abby, Bahar Dasgeb, Moinuddin Hassan, Franck Amyot, Victor Chernomordik, Yang Tao, Stavros G. Demos, et al. "Using Quantitative Imaging Techniques to Assess Vascularity in AIDS-Related Kaposi's Sarcoma." In Conference Proceedings. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE, 2006. http://dx.doi.org/10.1109/iembs.2006.259462.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Vogel, Abby, Bahar Dasgeb, Moinuddin Hassan, Franck Amyot, Victor Chernomordik, Yang Tao, Stavros G. Demos, et al. "Using Quantitative Imaging Techniques to Assess Vascularity in AIDS-Related Kaposi's Sarcoma." In Conference Proceedings. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE, 2006. http://dx.doi.org/10.1109/iembs.2006.4397377.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Schweitzer, Vanessa G. "Photodynamic therapy for treatment of AIDS-related mucocutaneous Kaposi's sarcoma (Invited Paper)." In OE/LASE '92, edited by Thomas J. Dougherty. SPIE, 1992. http://dx.doi.org/10.1117/12.60924.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Khan, N. A. J., H. Mehmood, A. Marwat, S. Liaquat, M. S. Eldin, and L. Naidu. "Respiratory Symptoms in a High-Risk Patient; Do Not Miss Pulmonary Kaposi's Sarcoma." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5199.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Daniluk, Urszula, Zuzana Berkova, Jillian Frances Wise, Rong-Hua Tao, Rezaeian Abdol Hossein, Shu Wang, Om Prakash, and Felipe Samaniego. "Abstract 1254: Kaposi's Sarcoma herpesvirus K1's transcellular inhibition of Fas-mediated apoptosis." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-1254.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Kainerstorfer, Jana M., Mark N. Polizzotto, Thomas S. Uldrick, Moinuddin Hassan, Rafa Rahman, Laleh Najafizadeh, Kathleen M. Wyvill, et al. "Multispectral imaging as a potential predictor of treatment efficacy for Kaposi's sarcoma skin lesions." In Biomedical Optics. Washington, D.C.: OSA, 2012. http://dx.doi.org/10.1364/biomed.2012.bsu3a.58.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Patel, Kunal, Craig Thurm, Kelly L. Cervellione, Farshad Bagheri, and Mohammad Maruf. "Rapidly Progressive Kaposi's Sarcoma With Prominent Oral And Pulmonary Manifestations In An HIV Patient." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a6200.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!